COVID-19 Switzerland
Information on the current situation, as of 16 August 2022
The key figures will be published each Tuesday at 15:30.
Status report, Switzerland and Liechtenstein
Laboratory-confirmed cases
Source: FOPH – Status: 16.08.2022, 06.08h
Difference since 09.08.2022 | 18 204 |
---|---|
14-day incidence from 10.08.2022Total per 100 000 inhabitants | 480,52 |
Total since 19.07.2022 | |
Number of cases | 97 401 |
Per 100 000 inhabitants | 1118,35 |
Laboratory-confirmed hospitalisations
Source: FOPH – Status: 16.08.2022, 06.08h
Difference since 09.08.2022 | 200 |
---|---|
14-day incidence from 10.08.2022Total per 100 000 inhabitants | 4,87 |
Total since 19.07.2022 | |
Number of hospitalisations | 946 |
Per 100 000 inhabitants | 10,86 |
Laboratory-confirmed deaths
Source: FOPH – Status: 16.08.2022, 06.08h
Difference since 09.08.2022 | 14 |
---|---|
14-day incidence from 10.08.2022Total per 100 000 inhabitants | 0,48 |
Total since 19.07.2022 | |
Number of deaths | 89 |
Per 100 000 inhabitants | 1,02 |
Viral load in wastewater
Source: FOPH – Status: 16.08.2022, 08.00h
Relative viral load | Number of treatment plants | Proportion of treatment plants |
---|---|---|
0-20% | 81 | 81,8% |
20-40% | 16 | 16,2% |
40-60% | 2 | 2,0% |
60-80% | 0 | 0,0% |
80-100% | 0 | 0,0% |
Total | 99 | 100,0% |
Vaccinated people
Source: FOPH – Status: 16.08.2022, 07.43h
Total population | |
---|---|
People with at least one dose | 70,26% |
Partially vaccinated | 0,98% |
Fully vaccinated | 69,29% |
With booster vaccination | 44,21% |
Hospital capacity, Switzerland
Source: FOPH – Status: 16.08.2022, 09.12h
Intensive care units | |
---|---|
Occupancy by COVID-19 patients15-day average from 08.08.2022 | 42,13 |
Total occupancy | 73,00% |
Occupancy by COVID-19 patients | 4,80% |
Total hospital capacity | |
Total occupancy | 77,60% |
Occupancy by COVID-19 patients | 3,40% |
Number of beds and occupancy in intensive care units
Virus variants
Source: FOPH – Status: 16.08.2022, 10.48h
Following the lifting of the special situation, the monitoring of variants of the virus will be adapted. There will be fewer numbers of samples sequenced and reporting delays are to be expected.
Estimated share of the different virus variants, 7-day average.
B.1.351 – Beta7-day average from 23.07.2022 | 0,0% |
---|---|
P.1 – Gamma7-day average from 23.07.2022 | 0,0% |
B.1.617.2, all subvariants AY – Delta7-day average from 23.07.2022 | 0,6% |
C.37 – Lambda7-day average from 23.07.2022 | 0,0% |
B.1.1.529 – Omicron7-day average from 23.07.2022 | 99,4% |
Tests and share of positive tests
Source: FOPH – Status: 16.08.2022, 06.08h
Difference since 09.08.2022 | 56 299 |
---|---|
Total since 19.07.2022 | 277 105 |
PCR tests | 210 649 |
Rapid antigen tests | 66 456 |
Per 100 000 inhabitantsCumulative PCR and rapid antigen tests | 3181,69 |
Share of positive PCR tests | 38,9% |
Share of positive rapid antigen tests | 42% |